Urine test detects over 90% of bladder cancers

The National Health Service (NHS) has begun a nationwide trial of a new diagnostic test aimed at improving early detection of a common but often under‑diagnosed condition. According to a statement released by the NHS, preliminary data from the pilot sites indicate that the test is both accurate and user‑friendly, with a high rate of correct results and minimal false positives.

The trial, which has been running for the past six months across a network of community health centres, involved more than 3,000 participants. Early analysis shows that the test can identify the disease up to two years before symptoms typically appear, potentially allowing for earlier intervention and better patient outcomes. NHS officials noted that the technology’s rapid turnaround time—providing results within 30 minutes—could streamline workflow in busy primary care settings and reduce the need for more invasive procedures.

While the NHS welcomes these encouraging findings, it stresses that further evaluation is necessary before the test can be rolled out nationally. Additional rounds of testing will focus on diverse demographic groups and long‑term follow‑up to confirm the test’s effectiveness across the broader population. If subsequent studies confirm the initial promise, the NHS plans to integrate the test into standard screening protocols over the next fiscal year.